The Minomic International Board has extensive experience in management, corporate finance, commercialisation of technologies and biotechnology.
Board members include:
Dr Brad Walsh (Chief Scientific Officer)
 Dr Walsh has 25 years experience in the biotechnology business and has enjoyed a successful career commercialising immunoassay kits and proteomics technologies and consumables as well as bioinformatics software. His products are being sold and supplied by major us corporations like Waters and Bio-Rad.
Before founding Minomic he was general manager of a not-for-profit public entity called the Australian Proteome Analysis Facility. This was a multi-million dollar facility established in 1995 by the Federal Government. Prior to this he led research groups in public institutions such as CSIRO, universities and hospitals. With his background and having successfully guided Minomic and MPL through six of the most turbulent years in biotech, both industry and government have eagerly sought his opinion as a thought leader and technologist. He has won prizes for the products being developed by the Company and was responsible for putting MPL on the 2006 business review weekly upstarts list of 200 fastest growing start-up companies.
David Burdis (Director)
 Mr Burdis is a qualified accountant and has worked in the chemical, telecommunications and financial services industries. He has held various senior/board positions, for both listed and unlisted companies, in Australia, the United Kingdom and Hong Kong including GFA International Limited, Swire Blanch Limited and OAMPS Limited. During his career he has been regularly involved in corporate acquisitions, divestitures and restructuring. Mr Burdis is the controlling shareholder of Qualita Management Pty Limited, a company providing outsourced management services to leading professional firms, including Ernst & Young and McGrathNicol and Government.
|
